{
    "2021-04-02": [
        [
            {
                "time": "",
                "original_text": "复星医药吴以芳：聚焦战略和人才，陆续推出创新产品",
                "features": {
                    "keywords": [
                        "复星医药",
                        "战略",
                        "人才",
                        "创新产品"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196)：创新疫苗国际领先 创新药接棒驱动成长",
                "features": {
                    "keywords": [
                        "复星医药",
                        "创新疫苗",
                        "国际领先",
                        "创新药",
                        "驱动成长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196)：创新转型催化成长 收入结构性变化愈加明显",
                "features": {
                    "keywords": [
                        "复星医药",
                        "创新转型",
                        "收入结构",
                        "变化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "光大证券 - 复星医药2020年报点评：业绩稳健增长，创新与国际化再上层楼【公司研究】",
                "features": {
                    "keywords": [
                        "光大证券",
                        "复星医药",
                        "年报",
                        "业绩增长",
                        "创新",
                        "国际化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国信证券 - 医药生物行业2021年4月投资策略：调整后更均衡，优选内生成长【行业研究】",
                "features": {
                    "keywords": [
                        "国信证券",
                        "医药生物",
                        "投资策略",
                        "内生成长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-02",
                "original_text": "A股早报2021年4月2日星期五",
                "features": {
                    "keywords": [
                        "A股",
                        "早报",
                        "2021年4月2日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "社保QFII持股路径曝光，化工电子板块各有所有爱",
                "features": {
                    "keywords": [
                        "社保",
                        "QFII",
                        "持股路径",
                        "化工",
                        "电子"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工",
                        "电子"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}